• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Interventional oncology turns profit for rad groups

Article

Interventional oncology practices can provide radiology departments with generous revenue despite the costly investment required to provide image-guided therapies.

Interventional oncology practices can provide radiology departments with generous revenue despite the costly investment required to provide image-guided therapies.

Dr. Catherine Tuite and colleagues at the University of Pennsylvania reviewed data from 68 patients who underwent radiofrequency ablation of liver tumors at Penn's outpatient interventional radiology clinic from 1999 to 2003. They recorded all aspects involved with the management of interventional oncology patients, including initial consultation, diagnostic imaging, intervention, and follow-up.

The relative value units drawn against standard payment rates from the Centers for Medicare and Medicaid Services provided the department with total professional revenue of $7000 and $10,000 per each new ablation and chemoembolization patient, respectively. The average revenue to the radiology practice totaled more than $120,000 annually, coauthor Dr. Michael C. Soulen said at the meeting of the Society of Interventional Radiology in April.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.